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In less than a year, more than 60 million cases of COVID-19 were reported worldwide.
Most of the data available still unclear. It affects vulnerable populations as those with
lowered immunity, chronic diseases and pregnant females. Many questions have to be
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answered as during pregnancy care should be given to mother, fetus and neonate. Also,
the obstetricians should follow the evidence-based recommendations during their routine
antenatal care and during labor. We reviewed the recent and available online published
researches since the outbreak of COVID-19 to know what we know about the impact of
the recent pandemic on the pregnancy and pregnant women. Till now it is reported that
being pregnant does not make women at more risk compared to general population,
however the use of prophylactic doses of LMWH is essential to prevent venous
thromboembolism. COVID-19 might lead to fetal growth restriction or miscarriage, but
the evidence to date remains uncertain. Vertical transmission of the virus is a possibility,
but it is not excreted in breast milk. With the evolution of many vaccines and many
immunological therapies, it is mandatory to assess their safety during pregnancy and
lactation.
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governmental efforts have been made on the

INTRODUCTION
Coronavirus disease 2019 (COVID-19) caused

development of potential efficacious vaccines (4).

by severe acute respiratory syndrome coronavirus

We accessed the data published on Pub Med, web

2 (SARS-CoV-2), that novel virus, started

of science and Scopus in the last year

spreading

toanswersmany

from

Wuhan,

China

in

questions

regarding

disease

December2019andledtoapandemicthataffectedthe

impact on mother, fetus and neonate. Also, to

wholeworldnotonlyonthehealth side but in most

know the evidence-based plan of management

of life’s activities(1).

during pregnancy, labor and lactation.

Consideringspreadingthroughrespiratorydropletso

Epidemiology of the disease

rsecretionsfrominfectedpatientsand

By November 27th, 2020, the world health

as

asymptomatic persons infected with SARS-CoV-

organization

2 carry high viral loads in their nasal secretions,

60,000,000 confirmed cases of COVID-19,

they can silently and efficiently spread the virus.

including 1.4 million deaths (5). The Egyptian

Most

countries

ministry of health reported more than 114,000

consideredlockdown,quarantine,andsocialdistanci

confirmed cases and more than 6,000 deaths were

ngforvaryingperiodsin2020tolimit the spread of

recorded by November 2020 (6).

the disease(2).

In their weekly updated COVID-19 pregnancy

COVID-19 affects people in different degrees

data,

from mild symptoms reaching to sever health

Prevention(CDC)estimatedthenumberofpregnant

impact requiring hospitalization and even ICU

womenwithCOVID-19intheUnited

admission. SARS-CoV-2 is known to have more

between January 22 and September 1, 2020, to be

of

the

impact on immunocompromised patients who are
vulnerable and have increased risk of ICU

(WHO)

Centers

for

reported

Disease

more

Control

than

and
States

20,216 including 44 deaths(7).
Effect of COVID-19 on pregnant women

admission, need for invasive ventilation, and

I.

death. Due to lower body immunity, patients with

During pregnancy a change of cell-mediated

known comorbidities like pregnancy, coronary

immunity

diseases, cancers, renal diseases, and diabetes are

weaknessoftheTh1typeactionwithstrengthenofthe

at more risk for a severe form of the disease (3).

Th2type(8).ThefunctionofTh1- type cells is anti-

Being a novel virus, we haven’t dealt with it

microbial and pro-inflammatory, and include

before and we don’t have a treatment or a
vaccine, the data we know about COVID-19 is
limited and studies are being run around the
world to help us understand its nature and update
guidelines for health care providers on how to

Immunology and pregnancy

normally

occurs,

this

includes

IFN-γ, IL-1α, IL-1β, IL-6, and IL-12; on the other
hand, the function of Th2 type is antiinflammatory as IL-4, IL- 10, IL-13, and TGFβ(9).
This alternation toward an anti-inflammatory
state occurs mainly during the second trimester

deal with patients with COVID-19. At the

which is considered essential to allow fetal

moment, there is a large amount of research being

growth (10).

done to discover suitable treatments. Great

This shift aims to provide an immunologically

https://mmj.mans.edu.eg/home/vol50/iss4/7
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tolerated state toward the placenta and the

2 infection makes us to expect less sever

fetusbyinhibitionofthebodyrejectiontounknownob

outcomes than SARS-CoV (15).

jectsinit.Thismakeswomenmore

vulnerable

to

A study published by clinicians in New York

pathogens

increase

their

suggested that being pregnant doesn't add more

susceptibility to a severe form ofthe diseases than

risk than the general population. Based on 43

non-pregnant(11).

females who were pregnant andtested positive for

Th1 type response is high and lasts for long time

SARS CoV-2 and the severity of their diseases

when looking to the cytokine analysis of

was similar to that of the non- pregnant patients:

peoplehavingsevereacuterespiratorysyndrome–

86% mild, 9% severe, and 5% critical, but

like

viruses

and

an

pregnant women’s number described in the study

80% genetic similarity to SARS-CoV-2, this

was not enough to get a final conclusion and they

leads to elevated levels of pro-inflammatory

had not been compared to individuals with similar

cytokines for more than fourteen days from the

age, gender or co-morbidities (16).

start of the disease (12). This causes an increased

II.

relatedcoronavirus(SARS-CoV),which

risk

of

maternal

massive

lung

has

Clinical presentation

damage,

intrauterine fetal death or premature delivery(13).

Evidence

shows

Fortunately, in COVID-19, The detected duration

populations who are asymptomatic or have very

and levels of both Th1 and Th2 type responses

littlesymptomsandtheyareconsideredviruscarriersa

are similar, with elevated levels of IFN-γ and IL-

ndtheyarespreadingthediseasein silence, but they

1β in circulation (pro- inflammatory cytokines) as

have unknown prevalence. A prospective study

well as of IL-4 and IL-10 (anti-inflammatory

based on 675 females who were pregnant and

cytokines). The mortality of patients having

admitted to 3 different hospitals at New York

SARS-CoV-2 infection is related to increased

City for labor, all of them were tested for

circulating levels of IL-6 which is considered the

COVID-19, found 70 women (10%) were

needle of the scale (14).

positive for SARS-CoV-2; 55 (79%) of those

As the inflammatory behavior plays a pivotal role

infected

in coronavirus course of infection, thecytokine

presentation at admission is shown in Table

profile and response recorded during SARS CoV-

1(17).

were

that

there

are

asymptomatic.

infected

Maternal

Table 1: Maternal presentation of COVID-19, stratified by being COVID-19 positive or negative depending on
RT-PCR result and the status of their symptoms (17)

Maternal presentation at admission
Temperature (°C), mean (SD)
HR (beats /minute), mean(SD)
RR (breaths /minute),mean (SD)
SpO2 (%), median (IQR)
WBC count, mean (SD)
Platelet count, mean (SD)

COVID-19 Positive cases
Symptomatic
Asymptomatic
n = 15
n = 55
37.0 (0.7)
36.8 (0.3)
91.8 (11.1)
88.4 (17.3)
19.5 (5.5)
18.0 (2.0)
99.0 (97.0–100.0)
99.0 (98.0–100.0)
8.8 (2.4)
9.0 (3.1)
231.8 (101.5)
207.9 (72.4)

COVID-19
Negative cases
P-value
n = 605
-0.17
-0.47
-0.11
-0.60
-0.78
-0.30

RT-PCR: reverse transcription-polymerase chain reaction.
HR: heart rate
RR: respiratory rate
SpO2: oxygen saturation
WBC: white blood cells
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Being asymptomatic, enough attention should be

among infected patients admitted to hospitals

dedicated to limit and contain thespread of the

(23).

virus among workers in the health sector, also

thromboembolism (VTE) is likely to be increased

among admitted women who are, or about to be,

due to SARS-CoV-2 infection. Many factors are

pregnant and among their newborns as well. This

to be considered to increase the risk of VTE

will be achieved by active protective measures for

including quarantines and isolation, at hospital

COVID-19 and by directing attention towards the

admission or at home, resulting in decreased

management of pregnant women in different

motility

hospital departments specifically obstetrics and

morbidity(21).

gynecology wards(15).

TherecentlyupdatedguidancefromtheRoyalColleg

Fortunately, only mild or moderate flu-like

eofObstetriciansandGynaecologists

symptoms will affect the majority of pregnant

version 11 advises that pregnant women should

women. While shortness of breath, anosmia,

stay well hydrated and mobile, VTE risk

cough, fever and headache are considered as

assessment performed during their pregnancy.

possible symptoms (18).

COVID-19 infection should be recognized as a

The most common symptoms reported by

transient risk factor. Low molecular weight

pregnant women in order are fever, coughing and

heparin (LMWH) should be prescribed to all

breathlessness. This is based on an interim report

pregnant ladies admitted to hospitals with

from the largest available cohort of pregnant

suspected or confirmed SARS-CoV-2 infection,

women admitted to hospital with SARS-CoV-2

unless they are expecting within 12 hours. After

infection to datewhich was published on 08 June

hospitaldischargeandfor10days,LMWH should by

2020 by United Kingdom Obstetric Surveillance

prescribed to all pregnant women with confirmed

System (UKOSS)(19).

COVID-19

Those who are immunosuppressed, elderly, or

asathromboprophylaxis.Anditshouldbeprescribedf

those with chronic diseases like cancer, diabetes

oralongerduration if the woman has a persistent

or chronic lung conditions are expected to have

morbidity(21).

marked hypoxia and moresevere symptoms

Effect of COVID-19 on the fetus

suggesting pneumonia (20). Early and rapid

Till now, available data does not suggest the risk

assessment,

supportive

of miscarriage to be increased by COVID-

treatment are necessary in pregnant women as

19.Thereisnoestablishedrelationshipbetweeninfect

they are expected to have infection with severe

ionandrisk of second trimester loss or miscarriage

symptoms(21).

according to studies and case reports on pregnant

III.

women with SARS-CoV and Middle East

identification

and

Venous thromboembolismprevention

The

and

respiratory
Pregnancyiswidelyrecognizedasahypercoagulable
state(22).Emergingevidenceshows the ability of
COVID-19 as well to make hypercoagulability

https://mmj.mans.edu.eg/home/vol50/iss4/7
DOI: 10.21608/mjmu.2021.82765.1027

risk

other

of

maternal

maternal

syndrome-related

or

venous

obstetric

(RCOG)

coronavirus

(MERS-CoV)(24).
At the moment, evidence does not suggest that
COVID-19 can cause fetal growth restriction
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(FGR); however, FGR is considered possible with

enoughprotectivemeasureswereapplied(n=3),bein

SARS as it affected two- thirds of pregnancies

gcausedbynotwearingmaskswhile

(25).

breastfeedingduetothelatediagnosisofthemotherint

Vertical transmission of COVID-19

hepostpartumperiod(n=2)(26).

There is a

controversy between available

In another established larger systematic review

researches on whether Coronavirus disease2019

published June 12th, 2020 based on 666

could be transmitted from the mother to her infant

newbornsdescribedasbeingborntoinfectedwomen

through the placenta antenatally or intrapartum.

withSARS-CoV-2,itconcludedthat 28 newborns

Whileameta-

out of 666 (4%) had confirmed SARS-CoV-2
th

analysispublishedonJuly17 ,2020on432newborns

infection after delivery (34).

whosemotherstested positive for SARS-CoV-2
infection before labor showed that there was a

Ontheotherhand,ameta-

total of 10 outof 432 (2.3%) neonates tested

analysispublishedinAugust2020, which included 236

positive for COVID-19(26).

pregnant women with COVID-19, concluded that

Inclusionandexclusioncriteriaforthisstudywererest

there is currently no evidence that SARS-CoV-2

ricttoensurethatifanewborntested positive it would

canbeverticallytransmitted.Astheirincludedstudies

be due to intra uterine transmission not due to

werenotsignificantwiththePvalue was greater than

after delivery contactwith the mother, doctors, or

0.05 which is not conclusive regarding vertical

the environment. This was achieved by testing

transmission. Without intrauterine tissue samples

newborns for COVID-19 shortly after their birth

being tested, they were not able to confirm

and they were given a certain care by health care

whether the SARS- COV-2 infection in neonates

providers, such as wearing masks by the health

was a result of intrauterine transmission(35).

care team and the mother, using negative pressure

Mode of delivery

wards, andisolation.

Delivery methods was questionable since the

The main clinical features and preventive

beginning of the outbreak. RCOG declared that at

measures used of the neonates with early

the moment evidence is not enough to indicate

COVID-19 in included studies are shown in

cesarean section in pregnantfemales who are

Table 2 (26).

positive for COVID-19(21).

Samples to test for SARS-CoV-2 in these studies

IntheUKOSSstudy,265infantswhowerebornforinf

were collected from the throat, serum, urine,

ectedwomenwithCOVID-19were tested, 253 of

feces, amniotic fluid, umbilical cord blood,

them were negative for SARS-CoV-2 infection.

placenta, breast milk, bronchoalveolar secretion,

12 (5%) of them tested positive for SARS-CoV-2;

cervical and vaginal secretions from the mother.

6 in the first 12 hours (4 were born by cesarean

Another 6 neonates tested positive but were

section and 2 by unassisted vaginal birth) and 6

excluded from the study due to being false

after 12 hours (4 born by cesarean section and 2

positive (n = 1), being infected 36 hours after

vaginally) Table 3(19).

delivery without being able to be sure if

Whenthebabyisbornbyvaginaldelivery,therateofne

Published by Mansoura Medical Journal, 2023

5

Mansoura Medical Journal, Vol. 50 [2023], Iss. 4, Art. 7
236

Mansour etal.,

onatalCOVID-19infectionisthe same. Therefore,

delivery over the other in delivering women with

evidence is not enough to choose singlemethod of

SARS-CoV-2 (34).

Table 2: Main clinical features and preventive measures used of the neonates with early COVID-19 in
included studies (26)
Age,
WeightandM
Method
of
Preventive measures and outcomes
Included
Country
ode
of
diagnosis
studies
delivery
RT-PCR:
N95 mask was used by the mother during
China n = 1
- C-section
Cord blood +
delivery. Immediate isolation of the newborn
Nie et al. (27)
throat swab + after birth. No
placenta
Treatment was given; discharged on the 16th
day.
Immediate separation and intubation of the
33 weeks
RT-PCR:
baby as the mother was sedated.
Alzamora et al.
Peru n = 1
2,97 Kg
Serology + throat Skin-to-skin care and cord clamping
(28)
C-section
swab
was delayed, and breastfeeding was not done.

Khan et al. (29)

Zeng et al. (30)

Hu et al. (33)

- 3,36 kg/3,57
Kg
Cesarean

China n = 3

40/40/31
weeks
3,25
Kg/3,36 Kg
/1,58 Kg
C-section

China n = 1

Dong et al. (31)

Hantoushzadeh
al. (32)

China n = 2

- 3,12 Kg
C-section

Iran n = 1

30 weeks
2,1 Kg
C-section

China n = 1

40 weeks
3,25 Kg
C-section

et

Babies were tested within the first day after
the delivery and was positive in two of them.

RT-PCR:
throat swab

RT-PCR:
anal and throat
swab

During labors, infectioncontrol
measures werestrictly applied.

RT-PCR:
An isolation room with negative pressure
Serology, throat
was used during delivery. Newborn showed
swab +
no clinical symptoms
vaginal secretions ofand was quarantined directly. And
themother
discharged on the 26th day.
RT-PCR:
throat swab

In the beginning, the test for the premature
newborn was negative.
On the 7th day, the neonate tested positive
during intubation.
RT-PCR: blood
Normal Chest X-ray reports on the 1st day of
, throat, feces and life. And the neonate showed nosymptoms.
urine

Table 3: Neonatal outcomes among liveborn infants of pregnant women with confirmed COVID-19 infection (19).
Neonatal outcomes
Negative SARS-CoV-2 test
Positive SARS-CoV-2 test
Positive test <12 hours of age
Positive test ≥12 hours of age

No. of liveborn babies of women with
COVID-19 (n=265)
253 (158 by Cesarean birth, 95 by vaginal birth)
12 (5%)
6 (4 by Cesarean birth, 2 by vaginal birth)
6 (4 by Cesarean birth, 2 by vaginal birth)

Breastfeeding and postnatal care

who is born to a COVID-19 positive mother is

There has been a debate between guidelines on

necessary. Or whether breastfeeding is a safe

whether separation of a newborn after delivery

practice. Each health system has its own guidance

https://mmj.mans.edu.eg/home/vol50/iss4/7
DOI: 10.21608/mjmu.2021.82765.1027
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on this issue as data are limited on neonatal care
fornewbornswhoarebornforwomenwhotestedposit
ive for COVID-19 in the 3 trimester(36).
Any possible hazard to the baby from contracting
the virus through breast milk is to be outweighed
the

well-known

long-term

benefits

of

breastfeeding (37).
It is reassuring that a recent study based on 24
lactating females who were COVID-19 positive,
found that PCR for their breast milk tested
negative for SARS-CoV-2. Table 4; however,
this evidence should be followed by caution as
the number of cases were small. The route of
infection during breastfeeding will be the direct
contact between the mother and her baby through
infective respiratory droplets (38).
In the light of this evidence, the recently
updated RCOG guidance version 11 gives a list
of advices for practitioners (21).

 Encourage close contact between mother and
her baby if she is not in need of ICU care.

 Encourage skin to skincontact if the baby is
not in need of special medical care.

 Encourage mother to breastfeed their babies
with wearing face mask during lactation.

 Frequent advices and support should be given
to all lactating mother.
Royal College of Pediatrics and Child Health
(RCPCH) precautions during feeding of the
baby should be followed to limit viral spread
(46).

 If the mother is critically ill, another healthy
person should take care of the baby.

 Hand washing is mandatory before dealing
with baby towels or supplies.

 Wearing fluid-resistant mask or a face
covering during lactation is recommended.

 Don’t use any face mask for babies to avoid

Published by Mansoura Medical Journal, 2023

suffocation.

 Adequate sterilization of baby feeding-bottles
before their use.

rd

by
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Conclusion
COVID-19 has affected a large number of
individuals worldwide with a mortality rate of
3.3%. Being a novel virus, the data we have on it
is limited so researches should continue to
improve our knowledge and help us take better
management plans and update our guidelines.
Most of the infected pregnant women will be
asymptomatic or have only flu-like symptoms. A
few percentages will get sever symptoms, but
being pregnant does notmake them at more risk
than the generalpopulation.
Pregnancy and COVID-19 are both a
hypercoagulable state, so prophylactic doses of
LMWHshouldbeprescribedtosuspectedorconfirme
dpregnantwomenwithCOVID-19.
Evidence of miscarriage or FGR as a
complication of COVID-19 is not available.
DependingupondatarelatedtoSARSCoVthereshouldbenoriskofmiscarriagebutFGR is
an establishedcomplication.
Vertical transmission of COVID-19 is a
possibility, but we need more focused researches
on larger numbers of newborns who are tested
just after delivery, the sample to be taken from
the umbilical blood and/or the placenta, and the
baby to be born with isolation and prevention
measures.
No available evidence to support one mode of
delivery over the other in COVID-19 patients. So
vaginal delivery will be the standard unless there
are other indications for cesarean section.
Mothersandtheirnewbornsshouldnotbeseparatedaft
erdelivery.AsSARS-CoV-2isnot excreted in breast
milk, women with COVID-19 should be
encouraged to breastfeed their babies while
considering the necessaryprecautions.
More national researches on the topic are needed
which will be more suitable for our community,
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hospitals, and health care system.
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